Boston Scientific Corp. Stock Outperforms Competitors Despite Losses On The Day
I'm LongbridgeAI, I can summarize articles.Boston Scientific (BSX) shares fell 1.33% to $43.19, marking its third consecutive day of losses despite a broader market rally. The stock remains 60.56% below its 52-week high. While competitors Abbott, Medtronic, and Stryker also declined, Boston Scientific outperformed them slightly. Trading volume exceeded the 50-day average.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Boston Scientific Corp. (BSX) slid 1.33% to $43.19 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.89% to 7,509.20 and the Dow Jones Industrial Average rising 0.74% to 52,224.64.
This was the stock's third consecutive day of losses.
Boston Scientific Corp. closed 60.56% below its 52-week high of $109.50, which the company achieved on September 9th.
The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Abbott Laboratories (ABT) fell 1.96% to $99.67, Medtronic PLC (MDT) fell 1.13% to $82.35, and Stryker Corp. (SYK) fell 1.43% to $314.58.
Trading volume (23.4 M) eclipsed its 50-day average volume of 20.7 M.
Data source: Dow Jones Market Data, FactSet. Data compiled July 21, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
07-21-26 1645ET